BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9547931)

  • 1. Clozapine and body mass change.
    Frankenburg FR; Zanarini MC; Kando J; Centorrino F
    Biol Psychiatry; 1998 Apr; 43(7):520-4. PubMed ID: 9547931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body-mass index, waist-size, waist-hip ratio and cardiovascular risk factors in urban subejcts.
    Gupta R; Rastogi P; Sarna M; Gupta VP; Sharma SK; Kothari K
    J Assoc Physicians India; 2007 Sep; 55():621-7. PubMed ID: 18051732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics.
    Hägg S; Söderberg S; Ahrén B; Olsson T; Mjörndal T
    J Clin Psychiatry; 2001 Nov; 62(11):843-8. PubMed ID: 11775042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia.
    Kivircik BB; Alptekin K; Calişkan S; Cömlekçi A; Orük G; Tümüklü M; Kürklü K; Arkar H; Türk A; Calişkan M; Yeşil S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):795-9. PubMed ID: 12921912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight-related increases in hypertension, hypercholesterolemia, and diabetes risk in normal weight male and female runners.
    Williams PT; Hoffman K; La I
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1811-9. PubMed ID: 17510467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of leptin concentration to gender, body mass index and age in Saudi adults.
    Al-Harithy RN
    Saudi Med J; 2004 Aug; 25(8):1086-90. PubMed ID: 15322603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
    J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
    Sitburana O; Rountree S; Ondo WG
    J Neurol Sci; 2008 Sep; 272(1-2):77-82. PubMed ID: 18556024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High body mass index and posttransplant weight gain are not risk factors for kidney graft and patient outcome.
    Marcén R; Fernández A; Pascual J; Teruel JL; Villafruela JJ; Rodriguez N; Martins J; Burgos FJ; Ortuño J
    Transplant Proc; 2007 Sep; 39(7):2205-7. PubMed ID: 17889138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and Smoking.
    Lau SL; Muir C; Assur Y; Beach R; Tran B; Bartrop R; McLean M; Caetano D
    J Clin Psychopharmacol; 2016 Apr; 36(2):120-4. PubMed ID: 26872115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
    Brunero S; Lamont S; Fairbrother G
    Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents.
    Spivak B; Musin E; Mester R; Gonen N; Talmon Y; Guy N; Roitman S; Kupchik M; Kotler M; Weizman A
    Int Clin Psychopharmacol; 1999 Jul; 14(4):229-32. PubMed ID: 10468315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients.
    John JP; Chengappa KN; Baker RW; Gupta B; Mortimer MT
    Ann Clin Psychiatry; 1995 Sep; 7(3):119-25. PubMed ID: 8646271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study.
    Piras M; Chahma J; Ranjbar S; Laaboub N; Grosu C; Plessen KJ; von Gunten A; Conus P; Eap CB
    Schizophr Bull; 2023 Jul; 49(4):944-952. PubMed ID: 36841954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study.
    Spokes J; Hollingworth S; Winckel K; Kisely S; Baker A; Cosgrove P; Siskind D
    Ther Adv Psychopharmacol; 2021; 11():20451253211000609. PubMed ID: 33796266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.